Read + Share
Amedeo Smart
Independent Medical Education
Khairunnisa NI, Yamasaki F, Miyata Y, Okada M, et al. The Efficacy of PCSK9 Inhibitors in Treating Hypercholesterolemia Caused by Lorlatinib: A Report of Two Cases. Clin Lung Cancer 2023;24:e176-e178.PMID: 37137771
Email
LinkedIn
Facebook
Twitter
Privacy Policy